Search for: "Astrazeneca LP" Results 101 - 120 of 156
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2010, 12:37 am by Kelly
Osmotica Pharmaceutical Corp (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement suit filed following Para IV certification: Astrazeneca Pharmaceuticals LP et al. v. [read post]
28 Jul 2010, 12:06 am by Kelly
(Patent Docs) Crestor (Rosuvastatin) – US: Patent infringement complaint following amended ANDA filing: AstraZeneca Pharmaceuticals LP et al. v. [read post]
20 Jul 2010, 12:58 pm by mcarzima@imediainc.com
In April of 2010, AstraZeneca LP and AstraZeneca Pharmaceuticals agreed to pay $520 million to resolve claims that the company marketed the drug Seroquel for off-label purposes and provided kick-backs to doctors who promoted its use. [read post]
30 Jun 2010, 5:52 am
(Docket Report) US: Update on reverse settlement agreements – Amici curiae brief filed with US Court of Appeals: In re Ciprofloxacin Hydrochloride Antitrust Litigation (IP Whiteboard) (PatLit) US: An uneven debate on ‘takings’ in pharmaceutical patent law (Patent Docs)   Products Aldara (Imiquimod) – US: Graceway’s injunction and Nycomed’s dismissal denied in Aldara suit (Patent Docs) Argatroban – US: Patent for Argatroban found valid, injunction issued… [read post]
29 Jun 2010, 6:01 pm by Duncan
(Docket Report) US: Update on reverse settlement agreements – Amici curiae brief filed with US Court of Appeals: In re Ciprofloxacin Hydrochloride Antitrust Litigation (IP Whiteboard) (PatLit) US: An uneven debate on ‘takings’ in pharmaceutical patent law (Patent Docs) Products Aldara (Imiquimod) – US: Graceway’s injunction and Nycomed’s dismissal denied in Aldara suit (Patent Docs) Argatroban – US: Patent for Argatroban found valid, injunction… [read post]
27 Jun 2010, 9:11 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
13 May 2010, 12:27 pm by Bexis
Astrazeneca Pharmaceuticals LP, 2009 WL 2231686 (M.D. [read post]
29 Apr 2010, 7:43 am by fraudfighters
Department Of Justice announced that it has entered into an agreement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to settle a False Claims Act lawsuit alleging that the companies submitted claims for payment to U.S. government health agencies (such as Medicare, Medicaid, and TRICARE) in connection with a scheme to illegally market the anti-psychotic drug Seroquel for uses that were not approved as safe and effective by the Food and Drug Administration. [read post]
28 Apr 2010, 7:14 am by Mark Zamora
From the DOJ Press Statement:AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services’ Health Care Fraud Enforcement Action Team (HEAT) announced today. [read post]
28 Apr 2010, 7:00 am by Lucas A. Ferrara, Esq.
Cuomo today announced that New York state will receive nearly $45 million as part of a $520 million federal and multi-state settlement with AstraZeneca LP (NYSE: AZN) concerning allegations that the large pharmaceutical company provided kickbacks to doctors and engaged in an off-label marketing campaign to promote its antipsychotic drug Seroquel. [read post]